Google
COR 株価分析 — CENCORA INC. (Healthcare >> Medical Distribution)
COR に関するよくある質問
CORのPER（株価収益率）は？
CENCORA INC.（COR）は現在PER 21.03倍で取引されています。
CORのROE（自己資本利益率）は？
CENCORA INC.のROEは75.01%です。
CORの配当利回りは？
CENCORA INC.の配当利回りは0.72%です。
CORの品質スコア（Quality Score）は？
当社のAIはCORの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
CORは今が買い時ですか？
当社AIのタイミングスコアは100点中87点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
CORはどのセクターに属しますか？
CENCORA INC.はHealthcare >> Medical Distributionセクターに分類されます（NYSE市場）
COR AI Analysis Summary
Our AI summary for COR: CENCORA INC. (NYSE), Healthcare >> Medical Distribution sector. The stock currently trades at a P/E of 21.03, ROE of 75.01%, a dividend yield of 0.72%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 311.34
Price
-0.89
(-0.29%)
Day Change
|
|
|---|
COR, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
2339
|
| Magic Formula Rank by ROE |
2339
|
| Magic Formula Rank by ROIC |
1696
|
| Price | 311.34 |
| PBV / Sector |
16.95 / -7.19
|
| Earning Per Share | 13.06 |
| PE / Sector |
21.03 / 20.35
|
| PEG or PE/Growth / Sector |
1,051.59 / 211.57
|
| Average 1M Daily Value |
327.33 M
GREAT
|
| Average 1W Daily Value |
287.06 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
12% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:40 |
| Symbol | COR |
| Name | CENCORA INC. |
| Sector | Healthcare >> Medical Distribution |
| Market | NYSE |
| Listed Shares | 194.56 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 60,747.80 / 45,764.92 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1 West First Avenue, Conshohocken, PA, United States, 19428-1800
Phone: 610 727 7000
Website: https://www.cencora.com
Employees: 47,000
Description: Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Distribution
Click a bubble to view stock details · Bubble size represents market capitalization share
